What directive has the Drug Controller General of India given regarding a popular combination drug for children
The Drug Controller General of India has issued a directive regarding the use of a specific combination drug for children.
The Drug Controller General of India (DCGI) has issued a directive regarding the use of a popular combination drug for children. Here are the key points of the directive:
- The DCGI has instructed pharmaceutical companies to immediately stop manufacturing, distributing, and selling the combination drug.
- This directive is applicable to all formulations of the combination drug that are meant for pediatric use.
- The ban on the drug is based on the findings of a committee that revealed potential risks associated with the drug's ingredients.
- The DCGI has advised healthcare professionals to discontinue prescribing this combination drug to children and switch to alternative medicines.
- Pharmacies and healthcare facilities have been instructed to remove any existing stocks of the combination drug from their shelves and return them to the manufacturer.
- Further investigations and studies will be conducted to evaluate the safety and efficacy of the drug, and its availability for children will be reconsidered based on the findings.
Answered
a year ago